You Position: Home > Paper

Application of nuclear medicine molecular imaging in the diagnosis and treatment of ovarian cancer

( views:4, downloads:0 )
Author:
No author available
Journal Title:
International Journal of Radiation Medicine and Nuclear Medicine
Issue:
12
DOI:
10.3760/cma.j.cn121381-202302004-00364
Key Word:
卵巢肿瘤;正电子发射断层显像术;体层摄影术,X线计算机;磁共振成像;体层摄影术,发射型计算机,单光子;Ovarian neoplasms;Positron-emission tomography;Tomography, X-ray computed;Magnetic resonance imaging;Tomography, emission-computed, single-photon

Abstract: Ovarian cancer is one of the common malignant tumors of female reproductive system. It is difficult to diagnose early, prone to relapse after initial treatment, and has a poor prognosis, so diagnosis and treatment still face great challenges. Imaging examination is an indispensable part in the diagnosis and treatment of ovarian cancer. Among them, nuclear medicine molecular imaging technology has become a highly potential non-invasive imaging method in the diagnosis and treatment of ovarian cancer. PET/CT has been widely used in the diagnosis, staging, treatment efficacy, prognosis, and recurrence evaluation of ovarian cancer. PET/MRI has shown significant advantages in the diagnosis and treatment of ovarian cancer due to its high soft tissue resolution and low radiation dose. SPECT/CT also plays an important role in the diagnosis and treatment of ovarian cancer due to the development of various new radioactive tracers. The authors review the application and research progress of PET/CT, PET/MRI and SPECT/CT about ovarian cancer, in order to further improve the value of molecular imaging technology in the diagnosis and treatment of ovarian cancer.

  • This article has no references!
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn